February 12, 2025
WLWT highlighted the University of Cincinnati’s Pooja Khatri and her son Ajai Nelson who have collaborated to launch the NIH StrokeNet Trial Finder app.
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
January 11, 2024
WVXU highlighted a new trial at the University of Cincinnati that will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
March 29, 2023
Neurology Advisor highlighted research from the University of Cincinnati that found rates of infective endocarditis-related stroke in the United States increased with affected patients more likely to be intravenous drug users.
January 10, 2023
Parkinson's News Today highlighted results of a recent trial, led in the U.S. by the University of Cincinnati's Alberto Espay, that found a liquid drug formulation was more effective than an oral formulation to control symptoms of Parkinson's disease.
February 13, 2023
Several national news outlets highlighted the University of Cincinnati's Eva Mistry presenting on the results of the BEST-II trial at the International Stroke Conference.
February 10, 2023
The University of Cincinnati's Joseph Broderick commented to HealthDay on the results of a new study finding a "neuroprotectant" drug alongside the standard surgical removal of a clot may lower the risk of death and disability following a stroke.
February 10, 2023
The University of Cincinnati's Eva Mistry presented research that found using medications to lower systolic blood pressure immediately after mechanical clot removal for acute ischemic stroke may not be safe or effective at the International Stroke Conference 2023.
September 12, 2024
National media outlets including Newsweek and U.S. News & World Report highlighted UC research led by Alberto Espay that found new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of the protein Aβ42 in the brain.